Universities should work with new forms of commercial partner to take their own cancer drugs to market and drive down the ‘spiralling’ cost of new medicines, leading experts propose.
Non-Profit Drug Development Could Cut Cost of Cancer Medicines
source: The Institute of Cancer Research